Pelvic Inflammatory Disease is an infection and inflammatory disorder involving the upper female reproductive tract, potentially affecting the uterus, fallopian tubes, ovaries and surrounding pelvic tissues. It commonly develops when microorganisms ascend from the lower genital tract into the upper reproductive organs. Sexually transmitted infections, particularly infections involving Chlamydia trachomatis and Neisseria gonorrhoeae, are important causes, but Pelvic Inflammatory Disease is frequently polymicrobial and can involve organisms that form part of the genital tract microbiota. The condition ranges from mild inflammation with subtle symptoms to severe infection involving abscess formation and widespread pelvic inflammation. Early recognition and treatment matter because inflammation can produce scarring even when symptoms are not dramatic.
The pathophysiology involves ascending infection followed by inflammation of reproductive tissues. Infection can move from the cervix through the uterus and into the fallopian tubes, where inflammation may damage delicate epithelial surfaces and later produce fibrosis and adhesions. The resulting structural damage can interfere with the normal transport of an egg through the tube and increase the risk of infertility and ectopic pregnancy. Inflammation can also spread into surrounding pelvic tissues and, in severe cases, produce a tubo-ovarian abscess. The severity of long-term consequences is not determined solely by how severe symptoms appeared initially, because some episodes are clinically subtle while still producing tissue damage. This makes prompt assessment important when the clinical pattern is compatible with upper reproductive tract infection.
Symptoms can include lower abdominal or pelvic pain, abnormal vaginal discharge, pain during sexual intercourse, abnormal uterine bleeding, fever and urinary discomfort. Pain may occur on both sides or be more prominent in one area, and symptoms can vary considerably between individuals. Some people have relatively mild symptoms or no obvious symptoms, particularly early in the disease. Examination may reveal cervical motion tenderness, uterine tenderness or adnexal tenderness, although these findings are not perfectly specific. Severe illness may involve high fever, vomiting, marked abdominal pain or systemic features. Because symptoms overlap with pregnancy-related, gastrointestinal, urinary and gynaecological conditions, the diagnosis requires clinical judgement rather than reliance on one symptom or test.
Diagnosis generally involves assessment of symptoms and pelvic examination, supplemented by testing for sexually transmitted infections and other relevant organisms. Nucleic-acid amplification testing can identify important bacterial infections, but negative tests do not exclude Pelvic Inflammatory Disease because the condition can be polymicrobial and infection may involve organisms that are not captured by a particular test. Pregnancy testing is important in reproductive-age patients with pelvic pain because ectopic pregnancy can be life-threatening and may resemble Pelvic Inflammatory Disease.
Imaging may be used when the diagnosis is uncertain, symptoms are severe or complications such as an abscess are suspected. There is no single definitive laboratory test that excludes the disease in every presentation, so clinicians often use a deliberately sensitive diagnostic approach to avoid missing treatable upper reproductive tract infection.
Treatment requires antibiotics capable of covering the range of likely organisms, and treatment is generally started promptly when clinical suspicion is sufficient rather than waiting for every test result. The precise regimen depends on current clinical guidance, local resistance patterns, allergies, pregnancy status and the severity of disease.
Sexual partners may require evaluation and treatment when a sexually transmitted infection is implicated or suspected, and sexual activity may need to be avoided until treatment has been completed and relevant infection-control advice has been followed. Severe infection, inability to take oral medication, pregnancy, suspected abscess or significant systemic illness can require hospital assessment and intravenous treatment. Treatment should address both the immediate infection and the prevention of reinfection, because a new episode can compound existing tubal damage.
Long-term complications are a major reason Pelvic Inflammatory Disease is clinically important. Tubal scarring can reduce fertility and increase the likelihood of ectopic pregnancy, while adhesions can contribute to persistent pelvic pain. A tubo-ovarian abscess can require prolonged antimicrobial treatment and sometimes drainage or surgery. Repeated episodes generally increase the cumulative risk of reproductive complications because additional inflammation can produce additional structural damage. Importantly, successful antibiotic treatment eradicates or controls the active infection but cannot reliably reverse established scar tissue. This distinction explains why early treatment is emphasised: antibiotics can prevent progression and reduce further damage but cannot necessarily restore anatomy already altered by fibrosis.
Prevention involves reducing the likelihood of sexually transmitted infections, appropriate testing when indicated, prompt treatment of identified infections and ensuring that relevant partners are assessed. Barrier methods can reduce transmission of many sexually transmitted infections, although no method eliminates every risk. A common misconception is that Pelvic Inflammatory Disease always produces severe symptoms; clinically silent or mildly symptomatic infection can still have consequences.
Another misconception is that a negative sexually transmitted infection test completely excludes the diagnosis, because the disease can involve multiple organisms and the initiating infection may no longer be detectable. The term should also be distinguished from isolated vaginitis or cervicitis because Pelvic Inflammatory Disease concerns inflammation of the upper reproductive tract and carries different potential complications.
The condition has major significance for reproductive health because preventable infection can produce consequences long after the acute episode has resolved. Its management combines infection control, antimicrobial treatment, partner management, prevention of reinfection and monitoring for complications. Clinical assessment must remain broad because pelvic pain can arise from many causes, including pregnancy-related emergencies, ovarian disorders, urinary disease and gastrointestinal pathology.
Delayed treatment increases the opportunity for inflammatory damage, while indiscriminate antibiotic treatment can contribute to adverse effects and antimicrobial resistance, so clinical criteria and appropriate testing remain important. The central medical principle is to recognise and treat suspected upper reproductive tract infection early while considering alternative diagnoses and the individual's reproductive circumstances.
